Notícias e Atividades da Boehringer Ingelheim US
Presença
Boehringer Ingelheim possui 16 subsidiárias incluindo Boehringer Ingelheim Animal Health USA, Boehringer Ingelheim Asia e Boehringer Ingelheim Belgium.
Executivos
Veja o organograma con seus 17 executivos principais
Biografias mais buscadas da Boehringer Ingelheim US
- Jean-Michel Boers, Country Managing Director, President and Chief ...
- Lars Dreesmann, President and Site Head, Fremont (promoted on Feb ...
- Amy Rudolph, Head Global Medical Affairs
Recentes movimentos de executivos em Boehringer Ingelheim US
- Brian Hilberdink, ingressou na Companhia como President, Human Pharma (Notícia publicada em 21 de fevereiro de 2025).
Criar um alerta
para seguir os movimentos de executivos da Boehringer Ingelheim US.
Farmacêutica
Boehringer Ingelheim possui 1.834 concorrentes concorrentes Pfizer (Estados Unidos), Eli Lilly (Estados Unidos) e Sanofi (França).
Popular M&A news in Farmacêutica
- Clario adquiriu NRx Pharmaceuticals (publicado em 18 de março de 2025).
- Knight Therapeutics has announced the acquisition of Paladin Labs (publicado em 12 de março de 2025).
- Jazz Pharmaceuticals adquiriu Chimerix (publicado em 6 de março de 2025).
Outros contatos sugeridos na indústria do Farmacêutica
Notícias
Últimos comunicados de imprensa de Boehringer Ingelheim US
- Novel antibody shows potential to transform treatment of rare form of psoriasis | boehringer-ingelheim.us
- Boehringer Ingelheim and Lilly announce the CAROLINA cardiovascular outcome trial of Tradjenta met its primary endpoint of non-inferiority compared with glimepiride | boehringer-ingelheim.us
- Everett Hoekstra Appointed President of Boehringer Ingelheim Animal Health USA Inc. | boehringer-ingelheim.us
- The maker of HEARTGARD® Plus (ivermectin/pyrantel) launches initiative to combat rising incidence rates of heartworm disease | boehringer-ingelheim.us
- Boehringer Ingelheim Announces Winners of 2018 Champions of the Cause Awards | boehringer-ingelheim.us
- Boehringer Ingelheim Exercises Option on Second Hepatic Disease Target From Research Collaboration with Dicerna | boehringer-ingelheim.us
- Boehringer Ingelheim and Vanderbilt University Announce Partnership to Develop Novel Therapies for Psychiatric Disorders | boehringer-ingelheim.us
- Boehringer Ingelheim and Lilly Partner with Duke Clinical Research Institute to Advance Multidisciplinary Care for People with Type 2 Diabetes and Cardiovascular Disease | boehringer-ingelheim.us
- Researchers focused on infectious respiratory disease in pigs may apply for Boehringer Ingelheim research awards | boehringer-ingelheim.us
- What You Should Know About Coliform Mastitis | boehringer-ingelheim.us
- View more press releases Close
Redes sociais sobre Boehringer Ingelheim US
- Boehringer Ingelheim US na Wikipedia, Google News e Yahoo Finance
- Boehringer Ingelheim US na LinkedIn, Twitter e YouTube
